Luris de Calero, MD
Family Medicine · Council Bluffs, IANPI 1750613618
Payments from drug & device makers
Across 68 payments — averaging $36.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$675
- Organogenesis Inc.$586
- Smith+Nephew$522
- Paratek Pharmaceuticals, Inc.$153
- Celularity Inc.$110
- Tactile Systems Technology Inc$95
- plus $332 from 10 others
What the payments were for
- Travel & lodging$1737%
- Food & beverage$2,30093%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 9 | $675 |
| Organogenesis Inc. | 13 | $586 |
| Smith+Nephew | 21 | $522 |
| Paratek Pharmaceuticals, Inc. | 5 | $153 |
| Celularity Inc. | 1 | $110 |
| Tactile Systems Technology Inc | 2 | $95 |
| KCI USA, Inc. | 4 | $66 |
| Integra Lifesciences Corporation | 3 | $64 |
| Hydrofera LLC | 2 | $49 |
| Hartmann USA, Inc. | 2 | $41 |
| Medtronic | 1 | $33 |
| Urgo Medical North America, LLC | 1 | $25 |
| Convatec Inc. | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $15 |
| Medline Industries LP | 1 | $13 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$243
- Grafix PRIME$125
- Grafix CORE$125
- Grafix XC$125
- Grafix PL PRIME$125
- Stravix$125
- UltraMist$110
How this compares
$2,473 in reported general payments places this provider in the 90th percentile of 1,357 family medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Monohydrate | 50 | $540 |
| Silver Sulfadiazine | 13 | $215 |
| SsdSilver Sulfadiazine | 14 | $171 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $160 |
| Triamcinolone Acetonide | 22 | $97 |
| Metronidazole | 21 | $90 |
| Minocycline Hcl | 13 | $63 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Council Bluffs
- Jennifer KayCouncil Bluffs$613K
- Kevin SheppardCouncil Bluffs$20K
- Kavish RohatgiCouncil Bluffs$14K
- Mel RocaCouncil Bluffs$13K
- Joseph WanzekCouncil Bluffs$13K
- James WhalenCouncil Bluffs$12K
- Barclay MonasterCouncil Bluffs$10K
- Krista HillCouncil Bluffs$8K
- Jamie ArmbrusterCouncil Bluffs$7K
- Nicholas GoetschWaterloo$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.